Implantable Cardioverter-defibrillators Market: Size, Growth, Regional Analysis, And Market Analysis
Implantable Cardioverter-defibrillators: An implantable cardioverter-defibrillator (ICD) is a device that can do cardioversion, defibrillation, and correct cardiac pacing and is implanted inside the body. The ICD is used to treat cardiac arrhythmias, ventricular fibrillation, and pulseless ventricular tachycardia that cause sudden cardiac arrest. As a result, the gadget is capable of rectifying the majority of life-threatening cardiac arrhythmias. The procedure for implanting an ICD is similar to that of implanting a pacemaker. When the heart is beating dangerously rapidly, an ICD is used to stimulate the cardiac muscle with a high-energy shock in order to reestablish a normal rhythm. Market Analysis: The Implantable Cardioverter-defibrillators Market was worth USD 9.3 billion in 2019 and is expected to increase to USD 12.1 billion by 2027, with a CAGR of 3.34 percent from 2020 to 2027. Demand for implantable defibrillators is predicted to rise globally due to a rapid increase in the